Brandon Holtrup

Dr. Holtrup is a Vice President at Oberland Capital. Prior to joining Oberland, Dr. Holtrup was an Associate Director in Global Analytics & Insight (Early Oncology) at AstraZeneca, where he focused on evaluating the commercial potential of early-stage assets. Previously, Dr. Holtrup was a Consultant at L.E.K. Consulting, where he provided strategic management advice to pharmaceutical and biotech companies. Dr. Holtrup completed a Ph.D. at Yale University, focusing on the molecular mechanisms governing metabolism and obesity. Dr. Holtrup also holds a B.S. from DePaul University in Biology.